Abstract. The expansion of CD4
+ CD25 + forkhead box (FOX)P3 + regulatory T (T reg ) cells has been observed in patients with Mycobacterium (M.) tuberculosis; however, the mechanism of expansion remains to be elucidated. The aim of the present study was to examine the role of the early secreted antigenic target 6(ESAT-6) and antigen 85 complex B (Ag85B) from M. tuberculosis on T reg cell expansion. To investigate the sensitivity of peripheral blood cultures to the M. tuberculosis ESAT-6 and Ag85B antigens, the proportion of circulating CD4 + CD25 + FOXP3 + T reg cells was determined using flow cytometry and the levels of FOXP3 mRNA were determined using reverse transcription quantitative polymerase chain reaction. The mRNA levels of FOXP3 and the proportion of circulating CD4 + CD25 + FOXP3 + T reg cells were increased in multiplicitous drug-resistant tuberculosis patients compared with those in healthy controls and patients with latent tuberculosis (TB) infection (LTBI) (P<0.001). The mycobacterial antigens ESAT-6 and Ag85B increased the expansion of the CD4 + CD25 + FOXP3 + T reg cells and the mRNA levels of FOXP3 in healthy controls and LTBI patients compared with the effect of Bacillus Calmette-Guerin (P<0.05). Additionally, the mRNA levels of FOXP3 were elevated in the LTBI patients following stimulations with the mycobacterial antigens (P=0.012). Therefore, the M. tuberculosis antigens and Ag85B induced CD4 + CD25 + FOXP3 + T reg -cell expansion, particularly in patients with LTBI. These findings indicated that CD4 + CD25 + FOXP3 + T reg cells may have a primary role in the failure of the host immune system to eradicate M. tuberculosis.
Introduction
Mycobacterium (M.) tuberculosis, the causative agent of tuberculosis (TB), was responsible for ~8.7 million novel cases of TB worldwide in 2007 (1) . Tuberculosis is considered to be a sustained immune response, which is induced by chronic, persistent antigen stimulation, results in immune suppression and generally fails to eradicate the M. tuberculosis infection in part. The host response, which involves several branches of the cellular immune system, predominantly consists of M. tuberculosis-specific T helper type 1 (Th)1 interferon (IFN)-γ-secreting CD4 + and CD8 + effector T cells (2) (3) (4) . CD4 + CD25 + regulatory T cells (T reg ), expressing the lineage marker forkhead box P3 (FOXP3), are important in controlling the immune response and in maintaining T-cell homeostasis (5, 6) . Several previous studies have found that the number of FOXP3 + T reg cells is increased in patients with active TB and are expanded at sites of active disease, where containment of inflammation and immune-mediated pathology is required most (7, 8) . A previous study by our group demonstrated that elevated levels of FOXP3 + T reg cells decreased following pulmonary resection in patients with pulmonary multiplicitous drug resistant tuberculosis (MDR-TB) (9) . This suggested that FOXP3 + cells may be essential during TB development; however, the mechanism underlying the increased levels of FOXP3 + cells in active TB patients remains to be elucidated. A variety of mycobacterial proteins and lipids are secreted into the cytoplasm of M. tuberculosis-infected macrophages, where they may be important in inhibiting the ability of macrophages to eradicate the bacterium (10) (11) (12) (19, 20) . Based on the immunogenicity of proteins secreted by M. tuberculosis, the present study hypothesized that T reg elevation may be induced by these proteins, including ESAT-6 and Ag85B, and that T reg activation may be important in the failure of the host immune response to eradicate M. tuberculosis.
Materials and methods
Study population. The study procedure was approved by the ethics committee of Shantou University Medical College (Shantou, China). Written informed consent was obtained from all individuals involved in the present study. Peripheral blood was obtained from 18 patients (10 males) with a median age of 51 years (range, 16-79 years), who had been diagnosed with MDR-TB at The Third People's Hospital of Shantou City (Shantou, China). The TB diagnosis was based on smear positivity and/or M. tuberculosis culture. The indication (therapeutic vs. diagnostic) and the main clinical pathologies are listed in Table I and the bacterial susceptibility assessment results are shown in Table II . A total of 18 uninfected volunteers (10 males) with a median age of 47 years (range, 25-73 years) were also included, who were tuberculin skin test-negative, had not been vaccinated and had no known exposure to M. tuberculosis. In addition, 18 patients with latent tuberculosis (TB) infection (LTBI; 9 males) with a median age of 35 years (range, 23-53 years) were selected according to the following recommended criteria (21) : Tuberculin skin test scores between 2+ and 3+, including a risk-stratified induration 72 h after intradermal injection of 2 units tuberculin (PPD-RT23 SST; Statens Serum Institute, Copenhagen, Denmark), chest radiographs were normal and the patients exhibited no clinical signs of active TB. All individuals were human immunodeficiency virus seronegative. No patients suffered from an immunodepressive illness or received immunosuppressive treatment.
Cell preparation and culture. Heparinized peripheral blood (600 µl) was suspended in 200 µl RPMI-1640 (HyClone, Thermo Fisher Scientific, Logan, UT, USA) containing 100 U/ml penicillin, 100 µg/ml streptomycin and 10% heat-inactivated fetal calf serum (Invitrogen Life Technologies, Carlsbad, CA, USA), termed complete medium, and was stimulated in vitro with recombinant ESAT-6 (cat. no. PRO-291; ProSpec-Tany, TechnoGene, Ltd., Rehovot, Israel), Ag85B (cat. no. PRO-589; ProSpec-Tany, Israel) or BCG (dead strain; cat. no 2009110102; Shanghai Institute of Biological Products, Shanghai, China). The final culture concentration of the secretory proteins was 4 µg/ml. The positive control used was phytohemagglutinin (PHA) and pure medium was used for the negative control. The blood was then incubated at 37˚C in 5% CO 2 for 72 h to separate the culture supernatant fluid from the cells. In the blood samples from six individuals (n=2 from each group) , multiple different antigen concentrations (0, 1 and 4 µg/ml) were used.
Flow cytometry. The whole blood was aliquoted (100 µl/tube) with 20 µl of the appropriate test antibody (1:5) The listmode data were acquired using an Epics XL flow cytometer (Beckman Coulter) and were analyzed using EXPO32 ADC analysis system (Expo 32v1. 
Reverse transcription quantitative polymerase chain reaction (RT-qPCR).
For RT-qPCR analysis of the mRNA expression of the forkhead transcription factor FOXP3, total RNA was isolated from leukocytes using a total RNA extraction kit for mammalian RNA (TRIzol reagent; cat.no. 15596-026; Invitrogen Life Technologies) according to the manufacturer's instructions. RT-PCR was performed in duplicate in a total volume of 20 µl in a LightCycler (Prism ® 7500; Applied Biosystems Life Technologies, Foster City, CA, USA), according to the manufacturer's instructions, using the following cycling conditions: 30 sec at 95˚C and 5 sec at 95˚C for 40 cycles followed by 31 sec at 60˚C. The normalized expression data were obtained by dividing the relative expression level for each sample by the relative expression level of β-actin for the same sample. The primer sequences used were as follows: β-actin forward, 5'-GGCGGCACCACCATGTACCCT-3' and reverse, 5'-AGGGGCCGGACTCGTCATACT-3'; and FOXP3 forward, 5'-ACCTGGAAGAACGCCATC-3' and reverse, 5'-TGTTCGTCCATCCTCCTTTC-3'. The results (FOXP3 / β-actin =2 �(CTFOXP3 � CTβ-actin ) were presented as the relative expression level for each gene (Fig. 1) . Table I . (Continued ).
Sputum
Clinical features Statistical analysis. All values are expressed as the mean ± standard deviation and all results were analyzed using SPSS 13.0 software (SPSS Inc., Chicago, IL, USA). Differences in the mean values between the patients and the controls were analyzed by one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference. + T reg cells in the MDR-TB patients were significantly increased (P<0.01) compared with those in the controls (CON) and the LTBI patients, whereas no significant difference (P= 0.093) was observed between those in the CON and LTBI patients (MDR-TB, 0.93±0.57%; CON, 0.24±0.14% and LTBI, 0.52±0.35%). The mRNA expression levels of FOXP3 were increased in the MDR-TB patients (0.0093±0.0027) compared with those in the CON (0.0043±0.0014) and LTBI (0.0066±0.0017) groups (P<0.05); however, the levels were similar in the LTBI and control patients (P=0.080) as shown in Fig. 2 .
Results

Percentage of CD4
Proportion of CD4 + CD25 + FOXP3 + T reg cells and the mRNA expression levels of FOXP3 increase depending on the concentration of ESAT-6, Ag85B or BCG.
Following cell culture with different concentrations (0, 1 and 4 µg/ml) of ESAT-6, Ag85B or BCG, the proportion of CD4 + CD25 + FOXP3 + T reg cells and the mRNA levels of FOXP3 increased with increasing concentrations of the mycobacterial antigens (Fig. 3) . However, due to the small sample number, no statistical analyses were performed. 
Strain Susceptibility assessment results appraisement -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
INH, isonicotinyl hydrazide; RFP, rifampicin; SM, streptomycin; EM,: ethambutol; RFT, rifapentin; CPM, capreomycin; OFX, levofloxacin; Th1321, prothionamide; KM, kanamycin; PAS, para-aminosalicylic acid; PNB, p-nitrobenzoic acid; TCH, 2-thiophenecarboxylic acid hydrazide; R, resistant; S, sensitive. (Fig. 4A and B) . Similar results were found for the mRNA expression levels of FOXP3 following stimulation with ESAT-6 (0.0251±0.0052; P<0.01), Ag85B (0.0261±0.0115; P<0.01) or BCG (0.0174±0.0193; P=0.130) compared with those in the unstimulated controls (0.0043±0.0014). As with the expansion of the CD4 + CD25 + FOXP3 + cells, the highest FOXP3 induction was observed following stimulation with Ag85B; however, the difference when compared with ESAT-6 or BCG was not statistically significant (P>0.05) (Fig. 4A and B) . (Fig. 4C and  D) . The mRNA expression levels of FOXP3 increased 2.2-fold following Ag85B stimulation (0.0205±0.0087) compared with those in the unstimulated control (0.0093±0.0027). No statistically significant changes were observed in the mRNA expression levels of FOXP3 following stimulation with ESAT-6 (0.0182±0.0062) or BCG (0.0113±0.0079) (Fig. 4C and D) . 
ESAT-6 and
E SAT-6 a n d Ag85B exp a n d th e prop or t io n of CD4
+ CD25 + FOXP3 + T reg cells and elevate the mRNA expression levels of FOXP3 in vitro in LTBI. Following cell culture for 72 h in the presence of ESAT-6, Ag85B or BCG, the proportion of CD4 + CD25 + FOXP3 + T reg cells and the mRNA expression levels of FOXP3 increased significantly. There was a significant difference in the proportion of CD4 + CD25 + FOXP3 + T reg cells between the simulated and unstimulated groups (P<0.001) (Fig. 4E and F) . Increases of 5.0-and 4.2-fold were obtained following stimulation with ESAT-6 (2.62±0.64) or Ag85B (2.16±0.52%), respectively (BCG 1.42±0.66%; unstimulated 0.52±0.35%). As shown in Fig. 4E and F, the mRNA expression levels of FOXP3 increased following stimulation with ESAT-6 (0.0486±0.0353) or Ag85B (0.0468±0.0254) only (unstimulated 0.0066±0.0017). No statistically significant difference in mRNA levels was observed between the BCG-stimulated group and the unstimulated control (P=0.830). When comparing BCG, ESAT-6 and Ag85B, the effects of ESAT6 and Ag85B were greater compared with those of BCG (P<0.05), although no statistically significant difference was observed between ESAT-6 and Ag85B (P=0.998) (Fig. 4E and F) .
Increased FOXP3 mRNA levels and proportion of CD4
+ CD25 + FOXP3 + cells following stimulation with ESAT-6, Ag85B or BCG. In the LTBI group, culture with ESAT-6 resulted in a six-fold increase in the mRNA expression of FOXP3 (Fig. 5A) , which was higher compared with those in the MDR-TB group (P=0.012); however, there was no significant difference from levels in healthy controls (P=0.151). In the cultures stimulated with Ag85B, the mRNA expression of FOXP3 increased six-fold in the LTBI group (Fig. 5C) , which was higher compared with that in the MDR-TB group (P= 0.007), but not significantly different from that in the healthy controls (P=0.102). BCG increased the mRNA expression of FOXP3 in the healthy controls only (MDR-TB, 0.22-fold; control, three-fold, LTBI, 1.4-fold; Fig. 5E ). The proportion of CD4 + CD25 + FOXP3 + T reg cells increased following stimulation and the increment was higher in the MDT-TB and LTBI groups + cells among total lymphocytes in the unstimulated (n=18), BCG (n=18), ESAT-6 (n=18) and Ag85B (n=18) and the mRNA expression level of FOXP3 in the peripheral blood of unstimulated (n=8), BCG(n=8), ESAT-6 (n=8) and Ag85B (n=8) patients prior to and following stimulation with different antigens (4 µg/ml) for 72 h. The positive control was PHA (n=6) and the negative control was medium (n=8). (A and B) show the results in uninfected controls; (C and D) show the results in the MDR-TB patients; (E and F) show the results in the LTBI patients. LTBI, latent tuberculosis infection; Ag85B, antigen 85 complex B; Esat-6, early secreted antigenic target 6; BCG, Bacillus Calmette-Guerin; PHA, phytohemagglutinin; FOXP3, forkhead box P3.
following culture with ESAT-6, Ag85B and BCG compared with that in the healthy controls (P<0.01; Fig. 5B, D and F) .
Discussion
Tuberculosis remains to be a challenging medical, social, and economic problem worldwide, especially in the third world (1) . The host response to infection with M. tuberculosis involves the cellular immune system, specifically the Th1-type interferon-γ-secreting CD4 + and CD8 + effector T cells (4) . This response assists in limiting bacterial replication and dissemination in vivo and results in important immunopathological features, including inflammation; however, it does not eradicate the infection (22) . The present study hypothesized that the immune system may possess regulatory mechanisms that suppress the response to persistent antigens. It has been previously reported that patients with TB have a high proportion of circulating T reg cells of the CD4 + CD25 + FOXP3 + phenotype compared with patients with LTBI or uninfected controls (7, 8) . A previous study by our group revealed that the elevated numbers of CD4 + CD25 + FOXP3 + cells observed in MDR-TB were found to decrease following removal of the M. tuberculosis burden by pulmonary resection (9) , which demonstrated that the increase in FOXP3 + T reg cells is a potential mechanism by which M. tuberculosis evades immune eradication. In individuals with tuberculosis, these cells have been observed to suppress the T-cell response to mycobacterial antigens, whereas the CD4 + CD25 + FOXP3 + cells from non-healthy individuals do not suppress the secretion of IFN-γ induced by protective mycobacterial antigens (8, 23) . The increased levels of functional CD4 + CD25 + FOXP3 + T reg cells in the peripheral blood of patients with TB may be either caused by or a result of the disease, which suggests that they are either generated or expanded during latent infection prior to the onset of disease. Although CD4 + CD25 + FOXP3 + T reg cells are naturally generated in the thymus (24) , they are induced in the periphery in mice (25) and humans (26) , which suggests that peripheral T reg cells may arise from antigenic challenge during the immune response.
In the present study, intracellular staining combined with flow cytometry and RT-qPCR analysis was performed to detect the expression of the most accurate available T reg markers, CD25 + In the present study, the highest levels of elevated FOXP3 mRNA were observed in the LTBI patients compared with those in the uninfected controls or the MDR-TB patients. Therefore, the peripheral CD4 + CD25 + FOXP3 + T reg cells may be involved in the early stages of TB pathogenesis. They may be generated and expanded from the peripheral blood mononuclear cells in LTBI and have been demonstrated to depress cellular immune responses in non-anergic patients with pulmonary TB (7, 8) . These results indicated that, in the majority of M. tuberculosis infections, a cell-mediated protective immune response controls the pathogen over several years and often for a lifetime without clinical consequences. Upon exposure of the infected individual to mycobacterial antigens, latent infection, re-exposure to M. tuberculosis or post-exposure BCG vaccination causes marked generation and expansion of CD4 + CD25 + FOXP3 + T reg cells. These cells then suppress the effective immune response, allowing mycobacteria to evade the control of the immune system and to proliferate and colonize vulnerable tissue, including the lungs (8) . This may be the reason why patients with LTBI reacquire the disease more easily upon re-exposure to M. tuberculosis. Antigen-specific γδ T cells may be involved in antimycobacterial immunity and complex patterns of γδT-cell immune responses have been observed in humans and animal models during early mycobacterial infections and chronic tuberculosis (27, 28) . ESAT-6, a protein secreted by the M. tuberculosis ESX-1 system, inhibits human T-cell immune responses and the secretion of IFN-γ, and CD4 + CD25 + T reg cells inhibit the production of IFN-γ by human memory γδ T cells in response to 30) . The results of the present study suggested that CD4 + CD25 + FOXP3 + T reg cells are important in immunity against M. tuberculosis by expanding in response to proteins secreted by M. tuberculosis, including ESAT-6 and Ag85B, and reducing the ability of the host to eradicate M. tuberculosis.
